Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life & Cardiovascular Risk in People With PAD
HY-PAD
1 other identifier
observational
26
1 country
1
Brief Summary
Peripheral arterial disease (PAD), a disabling condition, affects 800,000 Canadians. People with PAD suffer from poor quality of life due to leg pain, which makes walking difficult. They also have a high risk of heart disease. In November of 2017, the University of Ottawa Heart Institute (UOHI) launched Canada's first specific walking rehabilitation and cardiovascular risk reduction program dedicated to patients with PAD. An on-site, supervised exercise program to improve walking endurance and quality of life in PAD has been shown to be successful. However many patients are not able to participate in the on-site program due to barriers such as transportation, parking, or other commitments. Recently, a home-based walking program has also been shown to significantly improve walking endurance and quality of life among people with PAD. It was decided that a hybrid program, that has a short on-site program followed by a home-based program may allow more patients to participate and have the highest chance of success. The goal is to develop a new hybrid program for medical care in PAD patients in order to: (a) improve their walking distance, (b) improve their quality of life and (c) improve their cardiovascular risk. As part of this study the investigators will enrol 25 participants with PAD. Participants will be studied at baseline (before their first on-site class) and at 3 month follow up (after their last home program phone call).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2018
CompletedFirst Posted
Study publicly available on registry
August 28, 2018
CompletedStudy Start
First participant enrolled
July 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedMay 6, 2026
April 1, 2026
5.2 years
August 23, 2018
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6MWT
Improvements (increase) in 6 minute walk test total walking distance (meters) after 3 months
at 3 month follow up
Secondary Outcomes (2)
Improvements in quality of life
at 3 month follow up
improvements in Walking Impairment Questionnaire
at 3 month follow up
Interventions
Hybrid intervention that includes supervised on-site and home-based components in people with PAD
Eligibility Criteria
Participants who enroll in the UOHI PAD walking program
You may qualify if:
- Intermittent claudication with PAD documented by:
- ABI ≤0.90 or \>1.40;(14) or
- Anatomic evidence of lower extremity arterial stenosis ≥50% (by lower extremity angiography, CT angiography, MR angiography or ultrasound)
- Ability to participate in the study (ability to walk)
- Willingness to provide informed consent
You may not qualify if:
- They have had previous lower extremity amputation
- They are unable to walk
- They have critical limb ischemia or open lower extremity wounds.
- Patient is unable to read and understand English or French
- Patient is unable, in the opinion of the qualified investigator or referring physician, to comprehend and participate in the exercise intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ottawa Heart Institute Research Corporationlead
- AFP Innovation Fundcollaborator
Study Sites (1)
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thais Coutinho, MD
Ottawa Heart Institute Research Corporation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2018
First Posted
August 28, 2018
Study Start
July 9, 2019
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
May 6, 2026
Record last verified: 2026-04